Literature DB >> 6370287

Serum thymidine kinase in acute leukaemia.

H Hagberg, S Gronowitz, A Killander, C Källander, B Simonsson, C Sundström, G Oberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370287      PMCID: PMC1976763          DOI: 10.1038/bjc.1984.82

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  20 in total

1.  Prognostic factors in acute leukemia.

Authors:  E A Gehan; T L Smith; E J Freireich; G Bodey; V Rodriquez; J Speer; K McCredie
Journal:  Semin Oncol       Date:  1976-09       Impact factor: 4.929

2.  Regulation of thymidine kinase synthesis in human cells.

Authors:  L J Bello
Journal:  Exp Cell Res       Date:  1974-12       Impact factor: 3.905

3.  Thymidine kinase activity in the human bone marrow from various blood diseases.

Authors:  K Nakao; S Fujioka
Journal:  Life Sci       Date:  1968-04-15       Impact factor: 5.037

4.  Pretreatment flow cytometry of DNA content in adult acute leukemia.

Authors:  G M Dosik; B Barlogie; T L Smith; E A Gehan; M J Keating; K B McCredie; E J Freireich
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

5.  Thymidine kinase isoenzymes in human malignant lymphoma.

Authors:  P H Ellims; M B Van der Weyden; G Medley
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

6.  Factors related to length of complete remission in adult acute leukemia.

Authors:  M J Keating; T L Smith; E A Gehan; K B McCredie; G P Bodey; G Spitzer; E Hersh; J Gutterman; E J Freireich
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

7.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

8.  A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models.

Authors:  G Spitzer; K A Dicke; E A Gehan; T Smith; K B McCredie; B Barlogie; E J Freireich
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

9.  Prognotic significance of pretreatment proliferative activity in adult acute leukemia.

Authors:  J S Hart; S L George; E Frei; G P Bodey; R C Nickerson; E J Freireich
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  Factors influencing prognosis in adults with acute myelogenous leukaemia.

Authors:  D Crowther; M E Beard; C J Bateman; R L Sewell
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

View more
  8 in total

Review 1.  Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.

Authors:  M Hallek; L Wanders; S Strohmeyer; B Emmerich
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Serum thymidine kinase in diagnosis and follow-up of the small cell carcinoma of the lung.

Authors:  V Abbasciano; L Graziano; D Arcudi; G Felisatti; A R Cavallini; M G Reali; N Calia; S Campi; C Guglielmini
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

3.  Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

Authors:  A R Karlström; M Neumüller; J S Gronowitz; C F Källander
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

4.  Serum thymidine kinase, a possible marker for monitoring the effect of bone marrow transplant treatment in early recovery phase.

Authors:  M Suehiro; M Fukuchi; M Kohsaki; Y Takemoto; A Kanamaru; E Kakishita
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

5.  Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.

Authors:  M Hallek; B Emmerich; S Strohmeyer; R Busch; A Reichle; R Senekowitsch
Journal:  Klin Wochenschr       Date:  1988-08-15

6.  Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.

Authors:  P G McKenna; K L O'Neill; W P Abram; B M Hannigan
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

7.  Cytofluorometric determination of thymidine kinase activity in a mixture of normal and neoplastic cells.

Authors:  M Hengstschläger; E Wawra
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

8.  Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.

Authors:  S Rehn; J S Gronowitz; C Källander; C Sundström; B Glimelius
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.